Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1112 | 1113 | (Page 1114) | 1115 | 1116 | .... | 1146 | newer

    0 0

     



    (EMAILWIRE.COM, December 12, 2018 ) According to the new market research report "Vascular Closure Device Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) - Global Forecasts to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

    Don’t miss out on business opportunities in Vascular Closure Device Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=180101468

    The report provides an overall understanding of the market. In this report, the market is segmented on the basis of type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Among these type segments, the passive approximators segment is expected to account for the largest share of the vascular closure devices market in 2017. The access segment includes femoral access and radial access. The procedure segment includes interventional cardiology and interventional radiology/vascular surgery. The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

    A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

    Browse and in-depth TOC on "Vascular Closure Device Market "
    61 – Tables
    30 - Figures
    128 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/vascular-closure-device-market-180101468.html

    A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

    Geographic analysis reveals that the North American segment is expected to account for the largest share of the market in 2017, owing to the increasing prevalence of cardiovascular diseases in the U.S., growing trend of one-day surgery for vascular procedures, and the increasing number of research and clinical trials for vascular closure devices.

    Discount Available on Report @ https://www.marketsandmarkets.com/discountreports.asp?id=180101468

    The global mycoplasma testing market is dominated by North America, followed by Europe. North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centered at China, Japan, and India. The increase in generics development and manufacturing is a major growth driver for the pharmaceutical industry in this region. Growing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing are some factors propelling market growth in the Asian region.

    Key Players:
    Major industry players expand across geographies via partnerships and acquisitions in the future. Thermo Fisher Scientific Inc., Lonza Group Ltd., Merck KGaA, and Charles River Laboratories International Inc. have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features. These companies have products for all end users in this segment, a strong geographical presence, and more importantly, focus on continuous product innovations.

    Adjacent Markets Report Available - Request for bundle reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=180101468



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 12, 2018 ) According to the new market research report "Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022", published by MarketsandMarkets™, The global gastrointestinal stent market is projected to reach USD 452.6 Million by 2022 from USD 353.4 Million in 2017, at a CAGR of 5.1% during the forecast period.

    The increasing preference for minimally invasive surgeries and rising prevalence of GI cancers and other digestive diseases are the major factors driving the growth of the gastrointestinal stent market. The base year considered for the study is 2016, while, the forecast period is 2017 to 2022.

    Don’t miss out on business opportunities in Gastrointestinal Stent Market. Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=167758126

    Based on product, the biliary stent segment accounted for the largest share of the global gastrointestinal stent market. This can be attributed to the high prevalence of pancreatic cancer and biliary diseases as well as growth in the number of surgical procedures for the treatment of these diseases.

    Based on disease type, the biliary diseases segment accounted for the largest share of the gastrointestinal stent market. The large share of this segment is attributed to the high prevalence of gastrointestinal diseases in the elderly population.

    Based on end user, the ambulatory surgery centers segment is expected to register the highest CAGR during the forecast period. Scheduling delays for operation, slow operating room turnover times, and the need for increasing the number of operating rooms in hospitals are the major factors supporting the growth of ASCs.

    Browse and in-depth TOC on “Gastrointestinal Stent Market "
    177 – Tables
    32 – Figures
    182 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/gastrointestinal-gi-stent-market-167758126.html

    “North America dominated the gastrointestinal stent market in 2016.”
    North America accounted for the largest share of the gastrointestinal stent market in 2016, followed by Europe and Asia Pacific. The developed healthcare system, rising geriatric population, and high prevalence of gastrointestinal cancers are the major factors responsible for the large share of North America in the gastrointestinal stent market.

    Discount Available on Report @ https://www.marketsandmarkets.com/discountreports.asp?id=167758126

    Market Players
    Prominent players in the global gastrointestinal stent market are Boston Scientific (US), Cook Group (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Endo-Flex (Germany), and M.I. Tech (South Korea).

    Adjacent Markets Report Available - Request for bundle reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=167758126



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 12, 2018 ) Overview of Patient Data Management Systems Market
    The report covers the present and past market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period. The Global Patient Data Management Systems Market research report offers an in-depth analysis of the global market, providing relevant information for the new market entrants or well-established players. Some of the key strategies employed by leading key players operating in the market and their impact analysis have been included in this research report.

    Check out For Sample Report Here: https://www.reportsweb.com/inquiry&RW00012283842/sample

    Top Key Players in the Patient Data Management Systems Market: -
    Philips Healthcare, GE Healthcare, Dräger, Radiometer Medical, Cerner, IMD Soft, Elekta, Nexus AG, Mortara, Siemens Healthineers, Smiths Medical, Medset, UTAS,

    Firstly, the report provides a basic overview of the industry including its definition, applications and classifications. Then, the report explores the international and regional major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and market shares for each company. Through the statistical analysis, the report depicts the global and regional total market of Patient Data Management Systems industry including capacity, production, production value, cost/profit, supply/demand and import/export details.

    The scope of Patient Data Management Systems Market:
    This report focuses on the Patient Data Management Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

    Major Types of Patient Data Management Systems Market covered are:
    Single Function System
    Multifunction System

    Major Applications of Patient Data Management Systems Market covered are:
    ICUs
    General Ward

    Go For Interesting Discount Here: https://www.reportsweb.com/inquiry&RW00012283842/discount

    Table of Content

    1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
    1.5 Market by Application
    1.6 Study Objectives
    1.7 Years Considered

    2 Global Growth Trends
    2.1 Patient Data Management Systems Market Size
    2.2 Patient Data Management Systems Growth Trends by Regions
    2.3 Industry Trends

    3 Market Share by Key Players
    3.1 Patient Data Management Systems Market Size by Manufacturers
    3.2 Patient Data Management Systems Key Players Head office and Area Served
    3.3 Key Players Patient Data Management Systems Product/Solution/Service
    3.4 Date of Enter into Patient Data Management Systems Market
    3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product
    4.1 Global Patient Data Management Systems Sales by Product
    4.2 Global Patient Data Management Systems Revenue by Product
    4.3 Patient Data Management Systems Price by Product

    5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Patient Data Management Systems Breakdown Data by End User

    Get More Details @ https://www.reportsweb.com/inquiry&RW00012283842/buying

    Lastly, this report covers the market scene and its development prospects over the coming years, the Report likewise short manages the item life cycle, contrasting it with the significant items from crosswise over ventures that had just been popularized points of interest the potential for different applications, examining about late item advancements and gives a diagram on potential territorial pieces of the pie.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 13, 2018 ) According to the new market research report "Nerve Monitoring System Market by Product (Nerve Monitor, Electrode, Probe, Accessories), Technology (EEG, EMG, EP, ECOG), Application (Neurosurgery, ENT Surgery, Spine Surgery, Cardiovascular Surgery), End User (Hospital, ASC) - Global Forecasts to 2022", published by MarketsandMarkets™, The Global Nerve Monitoring System Market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period.

    Based on technology, the nerve monitoring system market is divided into electroencephalography, electromyography, electrocorticography and evoked potential. Among these segments, electromyography is expected to grow at the highest CAGR during the forecast period. Growing availability of reimbursements for EMG-assisted surgical procedures in developed countries, significant use of EMG nerve monitoring for intraoperative applications, and technological advancements in the field are expected to drive the growth of the electromyography segment in the next five years.

    Don’t miss out on business opportunities in Nerve Monitoring System Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=167758126

    The nerve monitoring system market is segmented by application into cardiovascular, neurosurgery, spine surgery, ENT surgery, and other applications. The neurosurgery segment is expected to have the largest share in the nerve monitoring system market in 2017, owing to increasing number of patients suffering from neurological disorders.

    Browse and in-depth TOC on “Nerve Monitoring System Market"
    177 – Tables
    32 – Figures
    182 - Pages
    Report @TOC - https://www.marketsandmarkets.com/Market-Reports/nerve-monitoring-system-market-155669000.html

    The nerve monitoring system market is segmented into hospitals and surgical centers and ambulatory surgical centers segment. The hospitals and surgical centers is projected to be the fastest-growing end-user segment due to increasing number of complex surgical procedures, and rising number of diagnostic and surgical procedures carried out at hospitals.

    Discount Available on Report @ https://www.marketsandmarkets.com/discountreports.asp?id=155669000

    Geographically, the nerve monitoring system market is segmented into North America, Europe, Asia, and the Rest of the World. North America is estimated to account for the largest share of the market in 2017, which is driven by the presence of a large patient population accompanied by a well-established medical reimbursement policy.

    Market Players
    The major players of the nerve monitoring system market are Medtronic (Ireland), NuVasive (US), Nihon Kohden (Japan), Bovie Medical (US), and Natus Medical (US), Checkpoint Surgical (US), Magstim (UK), Inomed (Germany), Erbe Elektromedizin (Germany), Dr. Langer Medical (Germany), EMS Handels (Austria), Neurovision Medical (US), and Halyard Health (Georgia).

    Adjacent Markets Report Available - Request for bundle reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=155669000



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 13, 2018 ) According to the new market research report "Superdisintegrants Market by Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin), Formulation (Tablet, Capsules), Therapeutic Area (Gastrointestinal, Cardiovascular, Neurology, Oncology, Hematology) - Global Forecast to 2023", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

    Don’t miss out on business opportunities in Superdisintegrants Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=198068672

    The global superdisintegrants market is projected to reach USD 536.5 million by 2023 from USD 366.4 billion in 2018, at a CAGR of 7.9%. Factors contributing to the growth of this market include the increasing adoption of orally disintegrating tablets, growing generics market, and the emergence of new superdisintegrants for the pharmaceutical industry. The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth.

    The report analyzes the global superdisintegrants market by type, formulation, therapeutic area, and region. By type, the synthetic superdisintegrants segment accounted for the largest share of the market in 2017. The large share of this segment can be attributed to the extensive consumption of these superdisintegrants in various pharmaceutical drug formulations due to the advantages offered such as effectiveness at lower concentrations as compared to starch and a lesser effect on the compressibility and flowability of the dosage form.

    Browse and in-depth TOC on "Superdisintegrants Market "
    124 – Tables
    37 - Figures
    182 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/superdisintegrants-market-198068672.html

    Based on formulation, the tablets segment accounted for the larger share of the global superdisintegrants market in 2017. The large share of this segment can be attributed to tablets being the most widely used dosage forms due to the benefits offered such as stability, low manufacturing cost (as compared to other dosage forms), easy product identification, and compactness, along with the increasing focus on orally disintegrating tablets and fast-dissolving tablets.

    Based on therapeutic area, the neurological diseases segment is expected to register the highest CAGR during the forecast period. This can be attributed to the increasing incidences of neurological disorders at the global level along with the growing demand for effective therapies.

    Discount Available on Report @ https://www.marketsandmarkets.com/discountreports.asp?id=198068672

    During this research study, major players operating in the superdisintegrants market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

    Browse Adjacent Markets @ Pharmaceuticals Market Research Reports & Consulting



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 12, 2018 ) Global Cancer Biomarkers market size will increase to Million US$ by 2025, from Million US$ in 2017, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Cancer Biomarkers.

    This study categorizes the global Cancer Biomarkers breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

    Request for sample here: https://www.reportsweb.com/inquiry&RW00012258454/sample

    Manufacturers for Cancer Biomarkers Market:
    Abbott Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Illumina,Inc., Agilent Technologies, Qiagen NV, Merck & Co., Inc., Hologic,Inc., Novartis AG, BioMerieux SA, Genomic Health, Inc., Affymetrix Inc., Roche Diagnostics Ltd.

    Global Cancer Biomarkers Market Breakdown by Type:

    · Protein Biomarkers

    · Genetic Biomarkers

    · Others

    Global Cancer Biomarkers Market Breakdown by Application:

    · Breast Cancer

    · Lung Cancer

    · Colorectal Cancer

    · Melanoma

    · Blood Cancer

    · Prostate Cancer

    · Ovarian Cancer

    · Stomach Cancer

    · Liver Cancer

    Cancer Biomarkers market report comprises key factor which can be useful for any new player in the industry. It is possible due to comparative analysis and overview that is provided in the report. By focusing on all the details in the report, it is more than enough for any newcomers entering the industry so that they can get a better knowledge and study the market before making any strategic decision.

    To know more about this report: https://www.reportsweb.com/inquiry&RW00012258454/buying

    Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market Share (%) and Growth Rate (%) of product in these regions, from 2018 to 2025 (forecast), covering United States, North America (Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa), RoW (Rest of World).

    Table of content:

    1 Study Coverage

    2 Executive Summary

    3 Market Size by Manufacturers

    4 Cancer Biomarkers Production by Regions

    5 Cancer Biomarkers Consumption by Regions

    6 Market Size by Type

    7 Market Size by Application

    8 Manufacturers Profiles

    9 Production Forecasts

    10 Consumption Forecast

    11 Value Chain and Sales Channels Analysis

    12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

    13 Key Findings in the Global Cancer Biomarkers Study

    14 Appendix

    Avail Discount for this report at: https://www.reportsweb.com/inquiry&RW00012258454/discount

    The study objectives are:

    · To analyze and research the global Cancer Biomarkers status and future forecast, involving, production, revenue, consumption, historical and forecast.

    · To present the key Cancer Biomarkers manufacturers, production, revenue, market share, and recent development.

    · To split the breakdown data by regions, type, manufacturers and applications.

    · To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

    · To identify significant trends, drivers, influence factors in global and regions.

    · To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 13, 2018 ) According to the new market research report “Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021", published by MarketsandMarkets™, The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.

    This report broadly segments the varicose vein treatment market into mode of treatment and products. The varicose vein treatment market, by products is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.

    This report covers the varicose vein treatment market across two major geographies, namely, North America and Europe. In this report, the North American varicose vein treatment market is further segmented into the U.S. and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the varicose vein treatment market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.

    Browse and in-depth TOC on “Varicose Vein Treatment Market”
    67 - Tables

    19 - Figures

    149 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/varicose-vein-treatment-market-22524107.html

    This research study involved the extensive use of secondary sources, directories, and databases (such as Hoovers, Bloomberg Business, Factiva, and Avention) to identify and collect information useful for this technology-based, market-oriented, and commercial study of the North America and Europe varicose vein treatment market. In-depth interviews were conducted with various primary respondents that mainly included key industry participants, subject-matter experts (SMEs), C & D level executives of key market players, and independent industry consultants, among others; to obtain and verify critical qualitative and quantitative information as well as to assess future market prospects of the varicose vein treatment industry.

    Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.) are the key players in the varicose vein treatment market.

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 12, 2018 ) Next Generation Sequencing (NGS) involves massively parallel sequencing of millions of DNA fragments, providing vast amounts of data quickly and at an affordable cost. This enables in-depth analysis of entire genomes at unprecedented levels, allowing researchers to explore questions/hypotheses that previously would have required years to answer.

    Global NGS Services market size will increase to xx Million US$ by 2025, from xx Million US$ in 2017, at a CAGR of xx% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for NGS Services.

    Request for sample here: https://www.reportsweb.com/inquiry&RW00012287797/sample

    The driving factors of the European NGS services market are faster and cost-efficient sequencing, rising preference of NGS over other platforms, and rising prevalence of inherited diseases.

    In addition, application of genomics in drug discovery, growing prevalence of cancer & other malignant diseases, and partnerships among companies, R&D centers, and universities supplement growth. However, the factors hindering the growth of the market are reliability on grants and funding from the government and decrease in capital expenditure from academic institutions. Technological advancements opened new opportunities in the market.

    Manufacturers for NGS Services Market:
    Beijing Genomics Institute (BGI), Cegat (Centre for Genomics and Transcriptomics) GMBH, DNA Vision SA, Eurofins Genomics Inc., Febit / Comprehensive Biomarker Center GMBH (CBC), Genomnia SRL, Mina Inc., Macrogen Inc., Microsynth AG, Seqomics, Source Bio Science

    Global NGS Services Market Breakdown by Type:

    · SBS

    · Ion Semiconductor

    · SBL

    · Pyro-Sequencing

    · SMRT

    Global NGS Services Market Breakdown by Application:

    · Oncology

    · Lung cancer

    · Breast cancer

    · Prostate cancer

    · Colorectal cancer

    · Others

    NGS Services market report comprises key factor which can be useful for any new player in the industry. It is possible due to comparative analysis and overview that is provided in the report. By focusing on all the details in the report, it is more than enough for any newcomers entering the industry so that they can get a better knowledge and study the market before making any strategic decision.

    To know more about this report: https://www.reportsweb.com/inquiry&RW00012287797/buying

    Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market Share (%) and Growth Rate (%) of product in these regions, from 2018 to 2025 (forecast), covering United States, North America (Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa), RoW (Rest of World).

    Table of content:

    1 Study Coverage

    2 Executive Summary

    3 Market Size by Manufacturers

    4 NGS Services Production by Regions

    5 NGS Services Consumption by Regions

    6 Market Size by Type

    7 Market Size by Application

    8 Manufacturers Profiles

    9 Production Forecasts

    10 Consumption Forecast

    11 Value Chain and Sales Channels Analysis

    12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

    13 Key Findings in the Global NGS Services Study

    14 Appendix

    Avail Discount for this report at: https://www.reportsweb.com/inquiry&RW00012287797/discount

    The study objectives are:

    · To analyze and research the global NGS Services status and future forecast, involving, production, revenue, consumption, historical and forecast.

    · To present the key NGS Services manufacturers, production, revenue, market share, and recent development.

    · To split the breakdown data by regions, type, manufacturers and applications.

    · To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

    · To identify significant trends, drivers, influence factors in global and regions.

    · To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.



    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 13, 2018 ) According to the new market research report “Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021", published by MarketsandMarkets™, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the vaccine adjuvants market along with the estimates and forecasts of the revenue and market share analysis.

    On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. The particulate adjuvants segment is expected to account for the largest share of the global market in 2016. The adjuvant emulsions segment, on the other hand, is projected to grow at the highest CAGR during the forecast period. This market is mainly driven by factors such as rising prevalence of diseases such as allergy, cancer, and HIV/AIDS; growing demand for advanced treatment options, and development of improved vaccine immunization.

    On the basis of route of administration, the market is segmented into oral, subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. Factors such as the rapidly growing geriatric population and vaccines for improved immunization are propelling the growth of this market. Rise in collaborations and acquisitions by private organizations and increased funding by government bodies for research and development are also expected to drive market growth.

    Browse and in-depth TOC on “Vaccine Adjuvants Market”
    90 - Tables

    42 - Figures

    156 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

    Geographically, the vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries.

    The major players in the vaccine adjuvants market are Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 13, 2018 ) According to the new market research report “HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End User (Laboratories, Hospitals, Physicians’ Offices & Clinics) - Global Forecast to 2020", published by MarketsandMarkets™, provides a detailed overview of the major drivers, restraints, opportunities, challenges, current market trends, and strategies impacting the market along with estimates and forecasts of revenue.

    The HPV testing and Pap test Market is poised to reach USD 4,523.1 Million by 2020 from USD 3,287.4 Million in 2015, at a CAGR of 6.6% from 2015 to 2020.

    On the basis of type of application, the global HPV testing and Pap test market is classified into two major segments, namely, cervical cancer screening and vaginal cancer screening. The cervical cancer screening application segment is expected account for the largest share of the Pap test market in 2015. This large share can be attributed to the increasing incidences of cervical cancer and government initiatives to spread the awareness about cervical cancer screening.

    Browse and in-depth TOC on “HPV Testing and Pap Test Market”
    80 - Tables

    52 - Figures

    124 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/hpv-testing-pap-test-market-214207371.html

    Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), Becton, Dickinson and Company (U.S.) are the key players operating in the HPV testing and Pap test market.

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 13, 2018 ) According to the new market research report “Wireless Health Market by Technology (WPAN, WLAN/Wifi, WiMAX), by Component (Hardware, Software, & Services), by Application (Patient Specific and Provider/Payer Specific), & by End Users (Providers, & Payers) - Analysis & Global Forecast to 2020", published by MarketsandMarkets™, This report studies the global wireless health market for the forecast period of 2015 to 2020. This market is expected to reach USD 110.12 Billion by 2020 from USD 39.03 Billion in 2015, at a CAGR of 23.1%.

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/wireless-healthcare-market-551.html

    The report segments the market of wireless health based on technologies, components, applications, end users, and regions. On the basis of technologies, the market is further segmented into WPAN, WLAN/WiFi, WiMAX, and WWAN. The WPAN technology market segment accounts for the largest share of the global market in 2015. The WPAN technology segment is further segmented into Bluetooth, RFID, Ant+, Zigbee, Z-wave, and UWB. The Bluetooth segment accounts for the largest share of the WPAN market in 2015. The large share of WPAN technologies can be attributed to the fact that these technologies are user friendly, secure, and affordable.

    On the basis of applications, the wireless health market is segmented into patient-specific applications and provider/payer-specific applications. Patient-specific applications account for a major share of the global wireless health market in 2015. Changing lifestyle demographics and the growing demand for quality healthcare have increased the adoption of patient-specific applications. Patient-specific applications are further segmented into physiological monitoring and patient communication applications.

    Browse and in-depth TOC on “Wireless Health Market”
    139 - Tables

    37 - Figures

    214 - Pages

    Allscripts Healthcare Solutions, Inc. (U.S.), AT &T, Inc. (U.S.), Cerner Corporation (U.S.), Omron Corporation (U.S.), Philips Healthcare (U.S.), Verizon Communications, Inc. (U.S.), Qualcomm, Inc. (U.S.), Aerohive Networks, Inc.(U.S.), Vocera Communications, Inc. (U.S.), and Alcatel-Lucent (U.S.) are some of the key players in the wireless health market worldwide.

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 13, 2018 ) The patient engagement solutions market is projected to reach USD 18.68 Billion by 2022 from USD 8.80 Billion in 2017, at a CAGR of 16.2%. The patient engagement solutions market is emerging and fragmented in nature with various regional and national players.

    Ask For Discount: https://www.marketsandmarkets.com/discountreports.asp?id=105975994

    McKesson Corporation (US) is one of the key players in the patient engagement solutions market in 2016. The company provides a wide range of patient engagement software, portals, and e-health solutions in the patient engagement solutions market. These products find application in a range of therapeutic areas including chronic diseases, women’s health, and mental health. To maintain its leading position and increase its customer base in the patient engagement solutions market, the company mainly focuses on expanding its market presence by enhancing its product deployment capabilities and product launches & enhancements. For instance, in September 2015, McKesson Specialty Health distributed its secure online patient engagement portal ‘My Care Plus’ to more than 250,000 cancer patients across the US.

    Cerner Corporation (US) is one of the major players in the patient engagement solutions market in 2016. It is a leading player in all developed geographies including the US, Europe, and Asia. The prime strength of the company is deployment of its innovative products and solutions at several healthcare organizations and networks. For instance, in July 2015, Cerner launched an EHR-agnostic tool aimed to improve the accuracy of fall risk detection by 60%, compared to traditional fall assessment methods. Cerner was ranked 34th on the Forbes list of the world’s most innovative companies in 2015. The company also focuses on other growth strategies such as partnerships and acquisitions to strengthen its position in the market. For instance, in 2016, Cerner partnered with Olathe Health System (US) to integrate its Millennium Revenue Cycle with the electronic health record (EHR). This relationship promoted opportunities to create and research advancements in technology to enhance cutting-edge patient care.

    Some of the other key players in the patient engagement solutions market include Allscripts (US), IBM (US), athenahealth (US), Orion Health (New Zealand), Getwell Network (US), Lincor Solutions (Ireland), Yourcare Universe (US), WelVU (US), Get Real Health (US), and Oneview Healthcare (Ireland).

    Request Bundle Of reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=105975994

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:
    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA : 1-888-600-6441
    sales@marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 13, 2018 ) According to research report "Pressure Monitoring Market By by Application (Respiratory, Glaucoma, Dialysis), Product (Device (Blood Pressure, Intracranial Pressure, Intraocular Pressure), Accessory), Procedure (Invasive), End User (Hospital, ASC, Diagnostic) - Global Forecast to 2020", provides a complete summary of the major drivers, restraints, challenges, opportunities, current market trends, and various strategies influencing the pressure monitoring market along with estimates and forecasts of the revenue and market share analysis.
    Browse 100 market data Tables and 45 Figures spread through 162 Pages and in-depth TOC on "Pressure Monitoring Market"
    https://www.marketsandmarkets.com/Market-Reports/pressure-monitoring-market-196787732.html
    The pressure monitoring market is expected to reach USD 8,040.6 Million by 2020 from USD 6,300.0 Million in 2015, growing at a CAGR of 5.0% from 2015 to 2020. Global market offers a favorable approach for monitoring of various kinds of pressures in the different parts of the body. Pressure monitoring plays an important role in detecting the health problems of a patient. The major fluctuations of pressure in the vital areas of the body may cause various chronic and acute diseases such as diabetes, cardiac arrest, and glaucoma.
    Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=196787732
    The report segments the global market on the basis of product type, procedure, therapeutic application, end user, and geography. On the product type, pressure monitoring devices segment is expected to account for the largest share in 2015, closely followed by the pressure monitoring accessories segment. The pressure monitoring device segment is further segmented into blood pressure monitoring devices, intraocular pressure monitoring devices, intracranial pressure monitoring devices. The blood pressure monitoring devices segment is expected to grow at the highest CAGR during the forecast period, owing to increasing prevalence of hypertension, increasing use of non-invasive devices, and patient compliance.
    On the basis of end user, the global market is segmented into hospitals, ASCs/clinics, home care settings, diagnostic centers and other end users.
    Request for special pricing on bundle reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=196787732
    Geographically, the market is dominated by North America, followed by Europe. North America is expected to account for the largest share of the global market in 2015, with Asia having the highest growth rate during the forecast period.
    Key players in the pressure monitoring market include Philips Healthcare (The Netherlands), GE Healthcare (U.K.), Welch Allyn, Inc. (U.S.), Medtronic (U.S.), and Drägerwerk AG & Co. KGaA (Germany).

    Contact:
    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA : 1-888-600-6441
    newsletter@marketsandmarkets.com



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 13, 2018 ) In order to study the many forthcoming movements and patterns prevailing in the global market, Fact.MR has included the latest Forecast report on Spine Devices Market to its vast database. The delivered study offers significant figures about the leading regions and applications which are functioning in the Global Spine Devices Market Forthcoming Trends by 2022, along with their market production, consumption, revenue, upcoming industry trends and forecasted market share details. Further, the accomplished market research report also anticipates that the concerned market would grow at a constructive CAGR until 2022.

    Request for Sample of this Global Market Research Report Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=259

    Spine devices are being used to decompress, stabilize the spine and treat various spine disorders. Key market players are focusing on producing innovative devices geared towards minimally invasive approach resulting in quick recovery and low pain. Nanotechnology is expected to be a game-changer in the treatment of spinal diseases. Spinal fusion and fixation devices are also in focus for simplification of complex spinal surgery procedures.

    A considerable increase in aging population, incidences of spinal cord diseases and rising number of spinal surgery across the world is driving the growth of spine devices. These spine devices are being developed with an aim to perform complex surgeries with a less invasive approach, resulting in a speedy recovery, less blood loss, and less pain. Manufacturers of spine devices are also coming up with new devices that can offer better diagnostics and treatment of various spine conditions. Spine devices are also being developed to simplify complex procedures including endoscopic spine surgery, vertebral compression fracture repair, interspinous fixation, interbody fixation, etc. Companies are also increasingly investing in research and development of advanced technologies including wireless sensor technology. 

    According to a new Fact.MR report, the global spine devices market is projected to reach US$ 8,348.2 million revenue by the end of 2022. The market is expected to witness robust growth during the forecast period 2017 to 2022. Implantable Polyetheretherketone (PEEK) is also gaining traction and has become one of the most common biomaterials used in spinal devices. Improving quality of care and ongoing research are also driving the global spine devices market.

    Spinal Plates to Emerge as Highly-Preferred Spine Device

    Spinal plates are being used on a large scale by surgeons to ensure fixation of the spine. Spine plates are anticipated to remain the top-selling product in global spine devices market during 2017-2022. Sales of spine plates is projected to bring in nearly US$ 2,000 million revenue by the end of 2022. Meanwhile, Spinal screws is expected to emerge as the second largest product in the global spinal devices market. Between 2017 and 2022, spinal screws segment is anticipated to create an incremental opportunity of over US$ 300 million.

    Request Global Market Report with TOC Here - https://www.factmr.com/report/259/spine-devices-market

    Hospitals to Witness Maximum Revenue Share

    Hospitals are expected to form as strong customer base in the global spine devices market as compared to orthopedic clinics. Towards the end of 2017, hospitals are anticipated to account for more than two-third of global revenue share. Hospitals as end users are projected to reach close to US$ 5,700 million by the end of 2022. Increasing number of spinal surgeries performed at hospitals is one of the factors driving demand for spinal devices.

    Competition Tracking

    The report also profiles companies that are expected to remain active in the expansion of global spine devices market through 2022, which include Exactech, Inc., NuVasive, Inc., DePuy Synthes, Amedica Corporation, Braun Melsungen AG, Arthrocare, Medtronic Plc., K2M Group Holding, Inc., Stryker Corporation, and Zimmer Biomet Holdings, Inc.

    Table of Content:

    Global Spine Devices Market - Executive Summary
    Global Spine Devices Market Overview
         2.1. Introduction

                2.1.1. Global Spine Devices Market Taxonomy

                2.1.2. Global Spine Devices Market Definition

         2.2. Global Spine Devices Market Size (US$ Mn) and Forecast, 2012-2022

                2.2.1. Global Spine Devices Market Y-o-Y Growth

         2.3. Global Spine Devices Market Dynamics

                2.3.1. Drivers

                2.3.2. Restraints

                2.3.3. Trends………………………… Continued

    To Buy Global Market Research Report, Go with this Link - https://www.factmr.com/checkout/259/S

    About FactMr

    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 13, 2018 ) The 'Global Oleic Acid (CAS 112-80-1) Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Oleic Acid (CAS 112-80-1) Market with a focus on the Chinese market. The report provides key statistics on the market status of the Oleic Acid (CAS 112-80-1) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail.

    Key Company Profile:
    • PT. musim mas
    • PT Ecogreen Oleochemicals
    • PT. Dua Kuda Indonesia
    • Cisadane Raya Chemicals
    • Eastman
    • VVF - Fatty Acids
    • Emeryoleo
    • Timur Oleochemicals Malaysia
    • Pacificoleo
    • KLK OLEO
    • Southern Acids In etc.

    Complete report on Oleic Acid (CAS 112-80-1) market spread across 145 pages and different major key players available @
    https://www.reportsnreports.com/contacts/discount.aspx?name=1584035

    The Oleic Acid (CAS 112-80-1) Market report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology post which the report explores into the international and Chinese players in the market. In this part, the report presents the company profile, product specifications, capacity, production value and 2013-2018 market shares for each company. The report depicts the global and Chinese market of Oleic Acid (CAS 112-80-1) Industry including capacity, production, production value, cost and profit, supply and demand and Chinese import-export. The total market is further divided by company, by country, and by application or type for the competitive landscape analysis. The report also estimates 2018-2023 market development trends of Oleic Acid (CAS 112-80-1) Industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Oleic Acid (CAS 112-80-1) Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2013-2023 global and Chinese Oleic Acid (CAS 112-80-1) Industry covering all important parameters.

    To know more about Oleic Acid (CAS 112-80-1) market Report request sample@ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1584035

    Table of Contents:
    Chapter One Introduction of Oleic Acid (CAS 112-80-1) Industry
    Chapter Two Manufacturing Technology of Oleic Acid (CAS 112-80-1)
    Chapter Three Analysis of Global Key Players
    Chapter Four 2013-2018 Global and Chinese Market of Oleic Acid (CAS 112-80-1)
    Chapter Five Market Status of Oleic Acid (CAS 112-80-1) Industry
    Chapter Six 2018-2023 Market Forecast of Global and Chinese Oleic Acid (CAS 112-80-1) Industry
    Chapter Seven Analysis of Oleic Acid (CAS 112-80-1) Industry Chain
    Chapter Eight Global and Chinese Economic Impact on Oleic Acid (CAS 112-80-1) Industry
    Chapter Nine Market Dynamics of Oleic Acid (CAS 112-80-1) Industry
    Chapter Ten Proposals for New Project
    Chapter Eleven Research Conclusions of Global and Chinese Oleic Acid (CAS 112-80-1) Industry

    More list of tables and figures available in the report.

    Purchase a Copy of this Report at https://www.reportsnreports.com/purchase.aspx?name=1584035

    About Us:
    ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. Feel free to Call us at +1 888 391 5441 or Email us at sales@reportsandreports.com


    Hrishikesh Patwardhan
    + 18883915441
    sales@reportsandreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 13, 2018 ) According to the new market research report "Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM) Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

    Don’t miss out on business opportunities in Breast Imaging Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=897

    Based on type, the global breast imaging market is segmented into ionizing breast imaging technologies and non-ionizing breast imaging technologies. The ionizing breast imaging technologies segment is subsegmented into analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), cone-beam computed tomography (CBCT), positron emission mammography (PEM), and electric impedance tomography. The non-ionizing breast imaging technologies segment includes breast MRI, breast ultrasound, optical imaging, automated whole-breast ultrasound (AWBU), and breast thermography.

    Browse and in-depth TOC on "Breast Imaging Market"
    107 – Tables
    39 - Figures
    150 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies-market-897.html

    Based on type, the global breast imaging market is segmented into two major categories, namely, ionizing technologies and non-ionizing technologies. Ionizing technologies are further segmented into eight subsegments, namely, analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast-specific gamma imaging (MBI/BSGI), cone-beam computed tomography (CBCT), positron emission mammography (PEM), and electric impedance tomography. The 3D breast tomosynthesis segment is expected to grow at the highest CAGR in the next five years, owing to the increasing regulatory approvals for 3D breast tomosythesis systems, benefits offered by these systems over other technologies, and higher patient accessibility offered by these systems.

    The non-ionizing breast imaging technologies segment is classified into five subsegments, namely, breast MRI, breast ultrasound, automated whole breast ultrasound (AWBU), breast thermography, and optical imaging. The automated whole-breast ultrasound (AWBU) segment is expected to grow at the highest CAGR in the next five years, owing to benefits such as high reproducibility, high resolution power with 3D capability, lower false positives, and faster imaging.

    Click to Avail Discount on Report - https://www.marketsandmarkets.com/discountreports.asp?id=897

    The breast imaging market is segmented into four major regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to dominate the global breast imaging market, majorly due to the rising incidence of breast cancer, favorable reimbursement scenario, ongoing technological advancements by market players, implementation of new breast density notification law in the U.S., rapid growth in geriatric population, and growing demand for the use of low levels or negligible radiation doses in the region. On the other hand, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. The high growth in this market can majorly be attributed to the rising patient population, increasing healthcare expenditure, higher government spending on breast cancer research studies, and implementation of several programs focused on creating awareness about the early detection of breast cancer.

    Key Players
    Hologic, Inc. (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Gamma Medica, Inc. (U.S.), Toshiba Corporation (Japan), Sonocine, Inc. (U.S.), Aurora Imaging Technology, Inc. (U.S.), and Dilon Technologies, Inc. (U.S.) are some of the key players operating in the global breast imaging market.

    Click for Adjacent Markets Report Available - Request for bundle reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=897



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 13, 2018 ) According to the new market research report “Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) - Global Forecast to 2023", published by MarketsandMarkets™, The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%. Growing demand for nucleic acid and protein sequencing, initiatives from government and private organizations, growing applications of bioinformatics, and the increasing number of collaborations between companies and research institutes are the major factors driving the growth of the market.

    Get Discount on Report: http://bit.ly/2L9NMCf

    The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%. The growing demand for nucleic acid and protein sequencing due to a reduction in sequencing costs, increasing research initiatives from government and private organizations, and the growing applications of bioinformatics are the major factors driving the growth of the market.

    Based on applications, the global bioinformatics market is categorized into genomics, chemoinformatics and drug design, proteomics, transcriptomics, and metabolomics. The metabolomics segment is expected to grow at the highest CAGR during the forecast period due to the rising usage of metabolomics in various disease-related projects.

    Browse and in-depth TOC on “Bioinformatics Market”
    189 - Tables

    27 - Figures

    195 - Pages

    For Bundles of Reports: http://bit.ly/2EpxvIF

    Market Players

    The bioinformatics market is highly competitive due to the presence of a large number of players. Few of the major companies in bioinformatics market are Thermo Fisher Scientific (US), Illumina Inc (US), Agilent Technologies (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US), and DNASTAR (US).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Research Insight: https://www.marketsandmarkets.com/ResearchInsight/bioinformatics-market.asp
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 13, 2018 ) According to the new market research report “Medical Device Reprocessing Market by Product (Reprocessed Device (Catheter, Endoscope, Laparoscopic Instruments, Biopsy, Pulse Oximeter), Service), Application (Cardiology, Gastroenterology, Arthroscopy, Orthopedic, Anesthesia) - Global Forecast to 2022", published by MarketsandMarkets™, The medical device reprocessing market is expected to reach USD 1,754 Million by 2022 from an estimated USD 823.5 Million in 2017, at a CAGR of 16.3%.

    Early buyers will receive 10% customization on reports @ http://bit.ly/2Bdky0y

    The key factors driving the growth of this market include the low prices of reprocessed medical devices as compared to new devices and the pressure to reduce the volume of regulated medical waste (RMW) generated by various healthcare organizations. However, the risk of transmission of surgical site infections associated with the use of reprocessed medical devices may hinder the growth of this market to a certain extent.

    Based on application, the market is segmented into cardiology; gastroenterology, urology, and gynecology; arthroscopy and orthopedic surgery; and general surgery and anesthesia. In 2016, the cardiology segment accounted for the largest share and is expected to grow at the highest CAGR during the forecast period. Growing geriatric population coupled with the increasing prevalence of cardiovascular disorders and increasing adoption of reprocessed cardiology and electrophysiology catheters in hospitals and other healthcare facilities are the major factors driving the growth of this segment.

    Browse and in-depth TOC on “Medical Device Reprocessing Market”
    75 - Tables

    24 - Figures

    145 - Pages

    Request Bundle Reports @ http://bit.ly/2SGUdiz

    The key players in the global medical device reprocessing market are Stryker Corporation (U.S.), Johnson & Johnson (U.S.), Vanguard AG (Germany), Medline ReNewal (U.S.), Medtronic plc (Ireland), SteriPro Canada, Inc., Pioneer Medical Devices AG (Germany), Vascular Solutions, Inc. (U.S.), HYGIA Health Services, Inc. (U.S.), ReNu Medical, Inc. (U.S.), SureTek Medical (U.S.), and Centurion Medical Products Corporation (U.S.).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Resaerch Insight: https://www.marketsandmarkets.com/ResearchInsight/reprocessed-refurbished-medical-devices-market.asp
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 13, 2018 ) According to the new market research report “Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Removal, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) - Global Forecast to 2023", published by MarketsandMarkets™, The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6%.

    Early buyers will receive 10% customization on reports @ http://bit.ly/2rwt32x

    Growth in this market is mainly driven by the growing adoption of minimally invasive and noninvasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, the availability of technologically advanced & user-friendly products, and the increasing demand for aesthetic treatments among men.

    Strategic analysis of the market developments between 2015 and 2018 revealed that growth strategies such as product launches, enhancements, and approvals; acquisitions; agreements, partnerships, and collaborations; and expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the medical aesthetics market. Among these business strategies, product launches, enhancements, and approvals and agreements, partnerships, and collaborations were the two most-widely adopted growth strategies.

    Browse and in-depth TOC on “Medical Aesthetics Market”
    170 - Tables

    37 - Figures

    225 - Pages

    Request Bundle Reports @ http://bit.ly/2QpSi5f

    Product launches, enhancements, and product approvals are the key growth strategies adopted by major players to strengthen their position in the global medical aesthetics market. In addition, strategies such as agreements, partnerships, and collaborations; acquisitions; and expansions were also adopted by several market players to remain competitive in the market.

    Allergan, plc (Ireland), Alma Lasers, Ltd. (Israel), Anika Therapeutics (US), Cutera, Inc. (US), Cynosure (US), El.En. S.p.A. (Italy), Fotona d.o.o. (Slovenia), Nestlé S.A. (Switzerland), Johnson & Johnson (US), Merz Pharma GmbH & Co. KGaA (Germany), Medytox, Inc. (South Korea), Sientra, Inc. (US), Sinclair Pharma PLC (UK), Syneron Medical, Ltd. (US), and Valeant Pharmaceuticals International, Inc. (US) are some of the key players operating in the global medical aesthetics market.

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Research Insight: https://www.marketsandmarkets.com/ResearchInsight/medical-aesthetics-market.asp
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 13, 2018 ) "Global Spinal Trauma Devices Market Analysis to 2025" is a specialized and in-depth study of the Spinal Trauma Devices industry with a focus on the global market trend. The report aims to provide an overview of global Spinal Trauma Devices market with detailed market segmentation by component, type, application and geography. The global Spinal Trauma Devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

    Get PDF sample Copy for study@ rnhttps://www.theinsightpartners.com/sample/TIPMD00002246/?nb


    The Report Provides A Detailed Overview Of The Industry Including Both Qualitative And Quantitative Data. It Provides Summary And Forecast Of The World Leading Spinal Trauma Devices Market Supported Product And Application. It Also Provides Market Size And Forecast Till 2025 For Overall Spinal Trauma Devices Market With Regard To 5 Major Regions, Namely; North America, Europe, Asia-Pacific (Apac), Middle East And Africa (Mea) And South America (Sam), Which Is Later Sub-Segmented By Various Countries And Segments. The Report Evaluates Market Dynamics Effecting The Market During The Forecast Period I.E., Drivers, Restraints, Opportunities, And Future Trend And Provides Exhaustive Pest Analysis For All 5 Regions.

    The List of Companies

    1. Zimmer Biomet
    2. B. Braun Melsungen AG
    3. Orthofix Internation N.V
    4. DePuy Synthes
    5. Globus Medical, Inc.
    6. Medtronic
    7. NuVasive, Inc.
    8. ReWalk Robotics
    9. Spinal Technology, Inc.
    10. Stryker Corporation

    An Exclusive Spinal Trauma Devices Market Analysis Report Created Through Broad Primary Research (Inputs From Industry Specialists, Companies, And Stakeholders) And Secondary Research, The Report Aims To Present The Analysis Of Global Spinal Trauma Devices Market By Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East And Africa. The Report Intends To Provide Cutting-Edge Market Intelligence And Help Decision Makers Take Sound Investment Evaluation. Besides, The Report Conjointly Identifies And Analyses The Rising Trends Alongside Major Drivers, Challenges And Opportunities Within The International Spinal Trauma Devices Market. Additionally, the Report Also Highlights Market.

    Also, Key Spinal Trauma Devices Market Players Influencing the Market Are Profiled within the Study Along With Their swot Analysis and Market Ways. The Report Also Focuses On Leading Industry Players With Data Like Company Profiles, Products And Services Offered, Financial Information Of Last Three Years, and Key Development In Past 5 Years.

    Inquire for Further Detailed Information @ https://www.theinsightpartners.com/discount/TIPMD00002246/?nb

    Reason to Buy
    • Save And Reduce Time Carrying Out Entry-Level Analysis By Identifying The Growth, Size, Leading Players And Segments Within The Global Spinal Trauma Devices Market
    • Highlights Key Business Priorities in Order to Help Companies to Realign Their Business Strategies.
    • The Key Findings And Recommendations Highlight Crucial Progressive Business Trends Within The Spinal Trauma Devices Market, Thereby Allowing Players To Develop Effective Long Term Strategies.
    • Develop/Modify Business Growth Plans By Using Substantial Growth Providing Developed And Emerging Markets.
    • Scrutinize In-Depth Global Market Trends And Outlook Coupled With The Factors Driving The Market, Similarly As Those Hindering It.
    • Enhance The Decision-Making Process By Understanding The Strategies That Underpin Commercial Interest With Respect To Product, Segmentation And Industry Verticals.

    About Us
    The Insight Partners Is A One Stop Industry Research Provider Of Actionable Intelligence. We Help Our Clients In Getting Solutions To Their Research Requirements Through Our Syndicated And Consulting Research Services.
    We Are Committed To Providing Highest Quality Research And Consulting Services To Our Customers. We Help Our Clients Understand Key Market Trends, Identify Opportunities, And Make Informed Decisions By Providing Market Research Solutions At An Affordable Cost.

    Contact Us:
    The Insight Partners,
    Phone: +1-646-491-987
    Email: sales@theinsightpartners.com
    Website: http://www.theinsightpartners.com/



    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

older | 1 | .... | 1112 | 1113 | (Page 1114) | 1115 | 1116 | .... | 1146 | newer